Trial Profile
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System Involvement and Who Are Currently Receiving Treatment With Elaprase
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2021
Price :
$35
*
At a glance
- Drugs Idursulfase (Primary)
- Indications Mucopolysaccharidosis II
- Focus Therapeutic Use
- Sponsors Shire
- 15 Sep 2014 New trial record